New challenges in the use of nanomedicine in cancer therapy

Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective

(2016) Javed Ahmad et al.   CURRENT PHARMACEUTICAL DESIGN

Ultra-High Throughput Synthesis of Nanoparticles with Homogeneous Size Distribution Using a Coaxial Turbulent Jet Mixer

(2014) Jong-Min Lim et al.   ACS Nano

Cancer active targeting by nanoparticles: a comprehensive review of literature

(2014) Remon Bazak et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Nanoparticles for Combination Drug Therapy

(2013) Liang Ma et al.   ACS Nano

Microfluidic Platform for Combinatorial Synthesis and Optimization of Targeted Nanoparticles for Cancer Therapy

(2013) Pedro M. Valencia et al.   ACS Nano

Nanomedicines as Cancer Therapeutics: Current Status

(2013) Sohail Akhter et al.   CURRENT CANCER DRUG TARGETS

First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies

(2013) Glen J. Weiss et al.   INVESTIGATIONAL NEW DRUGS

Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug

(2013) X. Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The big picture on nanomedicine: the state of investigational and approved nanomedicine products

(2012) Michael L. Etheridge et al.   Nanomedicine-Nanotechnology Biology and Medicine

Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery

(2012) S. Karve et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Is It Time for a Metagenomic Basis of Therapeutics?

(2012) H. J. Haiser et al.   SCIENCE

The clinical development of inhibitors of poly(ADP-ribose) polymerase

(2011) H. Calvert et al.   ANNALS OF ONCOLOGY

Clinical trials in the era of personalized oncology

(2011) Michael L. Maitland et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies

(2011) Huali Wu et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

(2011) Twan Lammers et al.   JOURNAL OF CONTROLLED RELEASE

Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge

(2011) Rochelle R. Arvizo et al.   Nanomedicine-Nanotechnology Biology and Medicine

Increased methylation variation in epigenetic domains across cancer types

(2011) Kasper Daniel Hansen et al.   NATURE GENETICS

Lipid Nanomedicines for Anticancer Drug Therapy

(2010) Ander Estella-Hermoso de Mendoza et al.   Journal of Biomedical Nanotechnology

The Complex Role of Multivalency in Nanoparticles Targeting the Transferrin Receptor for Cancer Therapies

(2010) Jin Wang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Autonomous in Vitro Anticancer Drug Release from Mesoporous Silica Nanoparticles by pH-Sensitive Nanovalves

(2010) Huan Meng et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Targeting of ανβ3-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles

(2010) Walter J Akers et al.   Nanomedicine

Suppression of Rev3, the catalytic subunit of Pol , sensitizes drug-resistant lung tumors to chemotherapy

(2010) J. Doles et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates

(2009) Andrzej Myc et al.   ANTI-CANCER DRUGS

Matrix-insensitive protein assays push the limits of biosensors in medicine

(2009) Richard S Gaster et al.   NATURE MEDICINE

Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles

(2009) C. H. J. Choi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

(2008) Jeffrey A Engelman et al.   NATURE MEDICINE

Seven challenges for nanomedicine

(2008) Wendy R. Sanhai et al.   Nature Nanotechnology